CAMP4 Therapeutics Corporation
CAMP · NASDAQ
12/31/2024 | 12/31/2023 | 11/30/2023 | 2/28/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $64 | $38 | – | $83 |
| Short-Term Investments | $0 | $0 | – | $0 |
| Receivables | $0 | $0 | – | $1 |
| Inventory | $0 | $0 | – | $0 |
| Other Curr. Assets | $2 | $1 | – | $1 |
| Total Curr. Assets | $66 | $40 | – | $84 |
| Property Plant & Equip (Net) | $10 | $13 | – | $17 |
| Goodwill | $0 | $0 | – | $0 |
| Intangibles | $0 | $0 | – | $0 |
| Long-Term Investments | $0 | $0 | – | $0 |
| Tax Assets | $0 | $0 | – | $0 |
| Other NC Assets | $2 | $2 | – | $1 |
| Total NC Assets | $12 | $15 | – | $18 |
| Other Assets | $0 | $0 | – | -$0 |
| Total Assets | $78 | $55 | – | $103 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | – | $2 |
| Short-Term Debt | $3 | $3 | – | $2 |
| Tax Payable | $0 | $0 | – | $0 |
| Deferred Revenue | $0 | $0 | – | $0 |
| Other Curr. Liab. | $5 | $4 | – | $3 |
| Total Curr. Liab. | $10 | $8 | – | $8 |
| LT Debt | $6 | $9 | – | $10 |
| Deferred Rev, NC | $0 | $0 | – | $0 |
| Deferred Tax Liab, NC | $0 | $0 | – | $0 |
| Other NC Liab. | $0 | $162 | – | $162 |
| Total NC Liab. | $6 | $171 | – | $172 |
| Other Liabilities | $0 | $0 | – | $0 |
| Cap. Leases | $9 | $12 | – | $12 |
| Total Liabilities | $15 | $179 | – | $180 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | – | $0 |
| Common Stock | $0 | $0 | – | $0 |
| Retained Earnings | -$212 | -$160 | – | -$111 |
| AOCI | $0 | $0 | – | $0 |
| Other Equity | $275 | $36 | – | $33 |
| Total Equity | $63 | -$124 | – | -$78 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | – | $0 |
| Total Liab. & Tot. Equity | $78 | $55 | – | $103 |
| Net Debt | -$55 | -$27 | $0 | -$71 |